Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3-O-Methyl-DGlucose

Magnetic Resonance in Medicine

Volumn 72, Issue 5, 2014, Pages 1375-1380

  Rivlin, Michal ^a   Tsarfaty, Ilan ^a   Navon, Gil ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

3 O Methyl D glucose; Breast cancer; Cest; Chemical exchange saturation transfer; MRI

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAMMALS; PATHOLOGY; TUMORS;

3-O-METHYL-D-GLUCOSE; BREAST CANCER; CEST; CHEMICAL EXCHANGE SATURATION TRANSFER; GRADIENT ECHO; LOW TOXICITY; MAMMARY TUMORS; PRE-SATURATION;

MOLECULAR IMAGING;

3 METHYLGLUCOSE; TUMOR EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER DIAGNOSIS; CHEMICAL EXCHANGE SATURATION TRANSFER MAGNETIC RESONANCE IMAGING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; IN VIVO STUDY; METASTASIS; MOLECULAR IMAGING; MOUSE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PROTON NUCLEAR MAGNETIC RESONANCE; ANIMAL; DISEASE MODEL; EXPERIMENTAL MAMMARY NEOPLASM; IMAGE ENHANCEMENT; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

3-O-METHYLGLUCOSE; ANIMALS; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; FEMALE; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MOLECULAR IMAGING;

EID: 84907938571     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.25467     Document Type: Article

References (27)

1. Warburg O. On the origin of cancer cells. Science 1956;123:309-314.
2. Foehrenbach H, Alberini JL, Maszelin P, Bonardel G, Tenenbaum F, de Dreuille O, Richard B, Gaillard JF, Devaux JY. [Positron emission tomography in clinical oncology]. Presse Med 2003;32:276-283.
3. Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med 2002;53:89-112.
4. Kubota K. From tumor biology to clinical Pet: A review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001;15: 471-486.
5. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002;2:683-693.
6. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79-87.
7. Vinogradov E, Sherry AD, Lenkinski RE. CEST: from basic principles to applications, challenges and opportunities. J Magn Reson 2013; 229:155-172.
8. Zaiss M, Bachert P. Chemical exchange saturation transfer (CEST) and MR Z-spectroscopy in vivo: A review of theoretical approaches and methods. Phys Med Biol 2013;58:R221-R269.
9. Liu G, Song X, Chan KW, McMahon MT. Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed 2013;26:810- 828.
10. Chan KW, McMahon MT, Kato Y, Liu G, Bulte JW, Bhujwalla ZM, Artemov D, van Zijl PC. Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med 2012;68:1764-1773.
11. Walker-Samuel S, Ramasawmy R, Torrealdea F, et al. In vivo imaging of glucose uptake and metabolism in tumors. Nat Med 2013;19:1067-1072.
12. Nasrallah FA, Pages G, Kuchel PW, Golay X, Chuang KH. Imaging brain deoxyglucose uptake and metabolism by gluco CEST MRI. J Cereb Blood Flow Metab 2013;33:1270-1278.
13. Rivlin M, Horev J, Tsarfaty I, Navon G. Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI. Sci Rep 2013;3:1-7.
14. Miller LP, Villeneuve JB, Braun LD, Oldendorf WH. Effect of pharmacological doses of 3-0-methyl-D-glucose and 2-deoxy-D-glucose on rat brain glucose and lactate. Stroke 1986;17:957-961.
15. Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K, Eddy S, Goodin S, White E, Dipaola RS. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 2010;70:1388-1394.
16. Raez LE, Papadopoulos K, Ricart AD, et al. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol 2013;71:523-530.
17. Dwarakanath BS, Singh D, Banerji AK, et al. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: Present status and future prospects. J Cancer Res Ther 2009;5(Suppl. 1):S21-S26.
18. Hwang YY, Kim SG, Evelhoch JL, Ackerman JJ. Nonglycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy. Cancer Res 1992;52: 1259-1266.
19. Xu YZ, Krnjevic K. Unlike 2-deoxy-D-glucose, 3-O-methyl-D-glucose does not induce long-term potentiation in rat hippocampal slices. Brain Res 2001;895:250-252.
20. Csaky TZ, Glenn JE. Urinary recovery of 3-methylglucose administered to rats. Am J Physiol 1957;188:159-162.
21. Jay TM, Dienel GA, Cruz NF, Mori K, Nelson T, Sokoloff L. Metabolic stability of 3-O-methyl-D-glucose in brain and other tissues. J Neurochem 1990;55:989-1000.
22. Martineau E, Tea I, Loaec G, Giraudeau P, Akoka S. Strategy for choosing extraction procedures for NMR-based metabolomic analysis of mammalian cells. Anal Bioanal Chem 2011;401: 2133-2142.
23. Hudson CS, Dale JK. Studies on the forms of d-glucose and their mutarotation. J Am Chem Soc 1917;39:320-328.
24. Spectral Database for Organic Compounds SDBS. http://sdbs.db.aist.-go.jp. Accessed May 1, 2014.
25. Harvey JM, Symons MC, Naftalin RJ. Proton magnetic resonance study of the hydration of glucose. Nature 1976;261:435-436.
26. Navon G, Lyon RC, Kaplan O, Cohen JS. Monitoring the transport and phosphorylation of 2-deoxy-D-glucose in tumor cells in vivo and in vitro by 13C nuclear magnetic resonance spectroscopy. FEBS Lett 1989;247:86-90.
27. Ling W, Regatte RR, Navon G, Jerschow A. Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (GAGCEST). Proc Natl Acad Sci USA 2008;105:2266-2270.